25 Jan 2024 • The US Food and Drug Administration (FDA) has approved a wearable belt device for postmenopausal women with osteopenia - the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with low bone density.

The device is worn around the hips and delivers calibrated mild vibrations to the hips and lumbar spine to help preserve bone strength and density. A vibration pack is mounted to the back of the belt.

Pivotal trials demonstrated the efficacy of Osteoboost in directly stimulating bone growth and preserving bone mineral density and strength by sending low-frequency vibrations directly to the lumbar spine and hips.

Source: Press Release | Read full story